Therapeutic drug monitoring for a personalized antibiotherapy

R. Bruch, C. Chatelle, A. Kling, C. Dincer, S. Wirth, S. Schumann, W. Weber, G. Urban

Research output: Chapter in Book/Report/Conference proceedingConference contributionpeer-review

Abstract

For the therapeutic drug monitoring (TDM) of β-lactam antibiotics at the patient's bedside, a novel approach of an electrochemical, microfluidic platform is presented. Herein, a highly sensitive, low-cost and versatile biosensor is combined with an enzyme linked assay (ELA), using the penicillin binding protein 3 (PBP-3) for a fast and facile detection of ß-lactams (less than 1 hour) from very low sample volumes (580 nl). The system applicability is successfully demonstrated by monitoring the antibiotic blood concentration of patients, receiving antibiotherapy (cefuroxime and cefazolin), while undergoing surgery.

Original languageEnglish
Title of host publication21st International Conference on Miniaturized Systems for Chemistry and Life Sciences, MicroTAS 2017
PublisherChemical and Biological Microsystems Society
Pages1189-1190
Number of pages2
ISBN (Electronic)9780692941836
StatePublished - 2020
Externally publishedYes
Event21st International Conference on Miniaturized Systems for Chemistry and Life Sciences, MicroTAS 2017 - Savannah, United States
Duration: 22 Oct 201726 Oct 2017

Publication series

Name21st International Conference on Miniaturized Systems for Chemistry and Life Sciences, MicroTAS 2017

Conference

Conference21st International Conference on Miniaturized Systems for Chemistry and Life Sciences, MicroTAS 2017
Country/TerritoryUnited States
CitySavannah
Period22/10/1726/10/17

Keywords

  • Electrochemical Biosensor
  • Microfluidic
  • Personalized Antibiotherapy
  • Point-Of-Care
  • ß-Lactams

Fingerprint

Dive into the research topics of 'Therapeutic drug monitoring for a personalized antibiotherapy'. Together they form a unique fingerprint.

Cite this